{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:38:12Z","timestamp":1790188692274,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.revmed.2009.10.433","type":"journal-article","created":{"date-parts":[[2010,1,7]],"date-time":"2010-01-07T04:16:40Z","timestamp":1262837800000},"page":"188-193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Complications infectieuses induites par le m\u00e9susage de la bupr\u00e9norphine haut dosage (Subutex\u00ae)\u00a0: analyse r\u00e9trospective de 42\u00a0observations"],"prefix":"10.1016","volume":"31","author":[{"given":"D.","family":"Grau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Faucherre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"L\u00e9glise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Pinzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Blayac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Reynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Peyri\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2009.10.433_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00003495-197917020-00001","article-title":"Buprenorphine: a review of its pharmacological properties and therapeutic efficacy","volume":"17","author":"Heel","year":"1979","journal-title":"Drugs"},{"key":"10.1016\/j.revmed.2009.10.433_bib2","unstructured":"Observatoire fran\u00e7ais des drogues et des toxicomanies (OFDT). Les traitements de substitution en France\u00a0: r\u00e9sultats r\u00e9cents 2004. Tendances no\u00a037-juin 2004."},{"key":"10.1016\/j.revmed.2009.10.433_bib3","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000050711","article-title":"Observation of psychoactive substance consumption: methods and results of the French Oppidum programme","volume":"7","author":"Thirion","year":"2001","journal-title":"Eur Addict Res"},{"key":"10.1016\/j.revmed.2009.10.433_bib5","unstructured":"D\u00e9cret no\u00a095-278\u00a0du 13\u00a0mars\u00a01995\u00a0relatif \u00e0 la pharmacovigilance."},{"key":"10.1016\/j.revmed.2009.10.433_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1345\/aph.1L628","article-title":"Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis","volume":"43","author":"Peyri\u00e8re","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.revmed.2009.10.433_bib7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.revmed.2008.11.011","article-title":"Puffy hand syndrome","volume":"30","author":"Arrault","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2009.10.433_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2008.03.025","article-title":"Buprenorphine in primary care: Risks factors for treatment injection and implications for clinical management","volume":"97","author":"Roux","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2009.10.433_bib9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0376-8716(02)00312-5","article-title":"Intravenous use of prescribed sublingual buprenorphine tablets by drug users receiving maintenance therapy in France","volume":"69","author":"Vidal-Trecan","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.revmed.2009.10.433_bib10","unstructured":"Enqu\u00eate Subgeo. Laboratoires Schering Plough, 2002."},{"issue":"Suppl 7","key":"10.1016\/j.revmed.2009.10.433_bib11","first-page":"59","article-title":"Persistent injecting practices in subjects on methadone or buprenorphine maintenance therapy. A study of 600\u00a0cases","volume":"152","author":"Fontaa","year":"2001","journal-title":"Ann Med Interne (Paris)"},{"key":"10.1016\/j.revmed.2009.10.433_bib12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0755-4982(05)84024-2","article-title":"Absence of correlation between mental disorders and high-dose buprenorphine. A case-control study","volume":"34","author":"Phan","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2009.10.433_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2004.05607.x","article-title":"Cutaneous complications of intravenous drug abuse","volume":"150","author":"Del Guidice","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.revmed.2009.10.433_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0755-4982(05)84025-4","article-title":"Complications infectieuses et m\u00e9susage de la bupr\u00e9norphine \u00e0 haut dosage","volume":"34","author":"Cazorla","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2009.10.433_bib15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1086\/528869","article-title":"Buprenorphine diversion: a possible reason for increased incidence of infective endocarditis among injection drug users? The Singapore experience","volume":"46","author":"Chai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2009.10.433_bib16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0755-4982(05)84026-6","article-title":"Enterobacter cloacae spondylodiscitis through misuse of high-dose intravenous buprenorphine","volume":"34","author":"Etchepare","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.revmed.2009.10.433_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.drugalcdep.2006.09.012","article-title":"Abuse liability of buprenorphine\u2013naloxone tablets in untreated IV drug users","volume":"88","author":"Alho","year":"2007","journal-title":"Drug Alcohol Depend"}],"updated-by":[{"DOI":"10.1016\/j.revmed.2010.04.001","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000}}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866309013575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866309013575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:25:50Z","timestamp":1759335950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866309013575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0248866309013575"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2009.10.433","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.revmed.2010.04.001","asserted-by":"object"}]},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complications infectieuses induites par le m\u00e9susage de la bupr\u00e9norphine haut dosage (Subutex\u00ae)\u00a0: analyse r\u00e9trospective de 42\u00a0observations","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2009.10.433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Soci\u00e9t\u00e9 nationale fran\u00e7aise de m\u00e9decine interne (SNFMI). Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}